Market Entry & Launch Strategy
Market landscape assessment, access barriers, launch sequencing, entry scenarios, opportunity prioritisation and cross-functional action planning.
Modular advisory support for Pharma, MedTech and Life Sciences teams preparing market entry, navigating reimbursement or accelerating adoption.
Market landscape assessment, access barriers, launch sequencing, entry scenarios, opportunity prioritisation and cross-functional action planning.
Reimbursement pathway assessment, pricing logic, comparator analysis, negotiation preparation and value proposition alignment.
Evidence-gap analysis, HTA narrative, economic value framing, budget-impact thinking and decision-relevant evidence prioritisation.
Regional dynamics, formulary and hospital access pathways, local decision-making, procurement routes and implementation priorities.
Identification and prioritisation of payers, institutions, clinicians, procurement actors, KOLs and other access influencers.
Access pathways for devices and technologies, hospital value proposition, mini-HTA thinking, procurement strategy and adoption planning.
Early access route assessment, pre-launch stakeholder needs, evidence preparation and risk/opportunity mapping before commercial launch.
Conversion of access strategy into an executable go-to-market plan focused on uptake, account priorities, channel strategy and measurable milestones.
Engagements can be scoped around one decision, one launch, one geography or a broader market-access workstream.
Define the scope